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The liver has a remarkable capacity to regenerate. Even with surgical removal (partial hepatectomy) of 70% of liver
mass, the remnant tissue grows to recover the original mass and functions. Liver regeneration after partial
hepatectomy has been studied extensively since the 19th century, establishing the long-standing model that
hepatocytes, which account for most of the liver weight, proliferate to recover the original mass of the liver. The
basis of this model is the fact that almost all hepatocytes undergo S phase, as shown by the incorporation of
radioactive nucleotides during liver regeneration. However, DNA replication does not necessarily indicate the
execution of cell division, and a possible change in hepatocyte size is not considered in the model. In addition, as
15–30% of hepatocytes in adult liver are binuclear, the difference in nuclear number may affect the mode of cell
division during regeneration. Thus, the traditional model seems to be oversimplified. Recently, we developed new
techniques to investigate the process of liver regeneration, and revealed interesting features of hepatocytes. In this
review, we first provide a historical overview of how the widely accepted model of liver regeneration was
established and then discuss some overlooked observations together with our recent findings. Finally, we describe
the revised model and perspectives on liver regeneration research.
Keywords: Akt, Cdks, Cellular hypertrophy, Cyclins, E2F family, Hepatocyte, Liver regeneration, mTOR, Partial
hepatectomy, PolyploidyIntroduction
The liver has an extraordinary capacity to regenerate
from various types of injuries [1,2]. The liver consists of
various cell types, including hepatocytes, biliary epithe-
lial cells, sinusoidal endothelial cells, stellate cells, and
Kupffer cells; however, hepatocytes, which carry out
most of the metabolic and synthetic functions of the
liver, account for about 80% of liver weight and about
70% of all liver cells [3]. In severely damaged liver with
impaired hepatocyte proliferation (in this review, the
term “proliferation” means an increase in cell number
due to cell division), facultative liver stem/progenitor
cells, which have the potential to differentiate into both
hepatocytes and biliary epithelial cells, proliferate and
are assumed to contribute to regeneration [2,4,5]. In
contrast, regeneration after surgical resection of a por-
tion of the liver (partial hepatectomy, PHx) does not* Correspondence: miyajima@iam.u-tokyo.ac.jp
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distribution, and reproduction in any mediumrequire such stem/progenitor cells; the remnant tissue
undergoes hyperplasia to recover the original liver mass
within about two weeks in rodents (Figure 1A and 1B)
[6-9]. In fact, this process is not a true “regeneration”
like that observed in limb or heart regeneration in newts
[10]. The liver does not recover the original lobular struc-
ture; rather, the remnant tissue simply increases in size
(Figure 1A). Although the term, “compensatory hyperpla-
sia” more accurately describes this phenomenon, we use
“liver regeneration” in this review, as it has been used
widely. The multi-lobular structure of rodent liver allows
the surgical resection of a lobe of choice to achieve differ-
ent degrees of liver mass loss by PHx (Figure 1A) [1]. As
the resection of lobes does not induce damage to the
remaining liver tissue, PHx has long been considered an
excellent experimental model for tissue regeneration.
The mention of liver regeneration by Prometheus in
Greek mythology indicates that ancient people had no-
ticed the regenerative capacity of the liver. Addition-
ally, descriptions of liver regeneration can be traced
back to the 19th century when liver mass restorationd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 The widely accepted model of liver regeneration. (A) Liver regeneration. A normal mouse liver after 70 or 30% PHx (Day 0), and
regenerated liver after 70 (Day 7) or 30% PHx (Day 4) are shown. Scale bars; 1 cm. (B) Liver weight change during liver regeneration after 70%
PHx. The regeneration requires circa 14 days to recover the original liver weight. The error bars are S.D. (n = 3–7 for each day). (C) The currently
accepted model of liver regeneration. In 70% PHx, the median lobe (ML) and the left lobe (LL) are removed, and the right lobe (RL) and caudate
lobe (CL) regrow to restore the liver mass. In the traditional model, each hepatocyte is thought to divide once or twice during liver regeneration
after 70% PHx. Potential alterations in size, nuclear number, and ploidy of hepatocytes are not taken into consideration.
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after removal of a small portion of the liver [11]. In the
early 20th century, it became possible to remove liver
lobes by ligating blood vessels to reduce damage to the
remnant liver tissue after surgery. In 1931, Higgins and
Anderson carefully formulated the currently used pro-
cedure for PHx [12]. Notably, they used the term “liver
restoration” instead of “liver regeneration” to distin-
guish clearly between compensatory hyperplasia and
true tissue regeneration [12]. Since then, liver regener-
ation after PHx in rodents has been studied extensively
for more than 80 years. Until the 1950s, liver regener-
ation was analyzed at mainly the tissue or cellular level
by microscopic observations [13-15]. In the 1960s, the
advent of electron microscopy enabled the analysis of
hepatocyte ultrastructure in liver regeneration [16-19].
Almost at the same time, the epoch-making research
tool of radioactive isotopes became available for
biological studies. This technology was used to show
that almost all hepatocytes incorporate radioactive
nucleotides during liver regeneration after 70% PHx
[20-25]. This landmark observation led to the estab-
lishment of the widely accepted concept that all
remnant hepatocytes actively divide to recover the
original cell number and liver mass (Figure 1C). This
long-standing model postulated that all hepatocytes
undergo roughly one or two rounds of cell division
after 70% PHx [8,26,27].Since the establishment of gene targeting technology
in mice in 1989 [28-30], much effort has focused on
identifying the genes required for liver regeneration.
Many genes have been reported to be involved in liver
regeneration after PHx [e.g., β-catenin, methionine
adenosyltransferase 1A (MAT1A), oncostatin M (OSM),
nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and
c-Met] [31-35]. Most of these studies focused on the
proliferation or survival of hepatocytes in accordance
with the long-standing model. Although an elegant and
simple model, accumulating evidence—including our
recent findings—suggest that the traditional model of
liver regeneration requires revision. We discuss these
observations and the proposed revised model in the
following sections.
Not all hepatocytes divide
The incorporation of radioactive nucleotides in hepato-
cytes during liver regeneration indicates that the cells
entered S phase; however, this DNA replication does not
necessarily mean that cell division occurred. If all hepa-
tocytes undergo S phase and cell division after PHx, the
ploidy should remain constant. However, it has long
been known that hepatocyte ploidy is increased after
PHx [14,36,37], suggesting that hepatocytes do not
undergo conventional cell division. Previously, no con-
vincing methods were available to investigate cell
division in hepatocytes; however, we recently developed
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using hydrodynamic tail vein injection (HTVi) for effect-
ive delivery of plasmids into hepatocytes [38-40]. In this
way, we permanently labeled hepatocytes with LacZ by
transiently expressing the Cre recombinase driven by the
albumin promoter in hepatocytes in Rosa26-LacZ re-
porter mice (Figure 2A and 2B). By randomly labeling a
small fraction of single hepatocytes, the fate of LacZ+
hepatocytes after PHx could be precisely traced; e.g., two
neighboring LacZ+ cells indicated that they were gener-
ated through one cell division, whereas single LacZ+
cells indicated that no cell division occurred (Figure 2A
and 2B). Recovery of the original mass after 70% PHx
occurred over the course of two weeks (Figure 1B), and
we counted the number of LacZ+ cells during the regen-
eration. Surprisingly, no cell division was observed in
more than 40% of hepatocytes, and the average number
of cell divisions two weeks after 70% PHx was estimated
as 0.7 times per hepatocyte, indicating that the number
of hepatocytes increased by only 1.6-fold. Moreover, in
the case of regeneration after 30% PHx (Figure 1A),
hepatocytes did not undergo cell division, even though
the original liver mass was recovered faster than that
from 70% PHx. Interestingly, only a marginal fraction of
hepatocytes entered into S phase after 30% PHx. Similar
observations of infrequent S phase progression after 30%
PHx were reported previously [14,41]. These observa-
tions indicate that hepatocyte proliferation alone does
not account for liver regeneration after PHx.
Hepatocytes enlarge
The organ size is determined not only by the cell number,
but also by the size of cells that constitute the organ [42].
Because the increase in hepatocyte number (1.6-fold in-
crease) alone could not account for the increase in the
liver weight (~2.4-fold increase after 70% PHx), we investi-
gated hepatocyte size by imaging cytometry. We found
that hepatocyte size increased significantly by 1.5-fold afterFigure 2 Single hepatocyte labeling assay for evaluation of hepatocy
the optimized HTVi in Rosa26-LacZ mice, single hepatocytes (singlets) are g
underwent a cell division cycle would result in a pair of neighboring labele
as a singlet. The frequency of cell division is estimated by counting the nu
and a doublet. A section of a regenerated liver with labeled hepatocytes a
(upper), and the labeled hepatocyte (lower) is an example of a singlet. Scalboth 30 and 70% PHx (Figure 3) [38]. This increase in cell
size alone accounts for the increased liver weight after
30% PHx, explaining the observation that hepatocytes do
not divide after 30% PHx. Moreover, a combination of
increased cell size and hepatocyte number account for the
increase in liver weight after 70% PHx (1.5 × 1.6 = 2.4).
Interestingly, increased hepatocyte size occurs as early as a
few hours after 70% PHx, much earlier than their entry
into the cell cycle, and peaks at 1 day after 70% PHx,
suggesting that cell size increase is the first response of
hepatocytes to the loss of liver mass. This very early stage
of liver regeneration (0–4 hr after PHx in mice) is known
as the “priming” phase, in which hepatocytes dramatically
change their gene expression to prepare for regeneration
[7,43]. Therefore, the change in transcriptional program
seems to be responsible for the immediate hypertrophy of
hepatocytes. Notably, the liver weight is almost unchanged
from 1 day to 2 days after 70% PHx (Figure 1B). Because
hepatocytes slightly decrease their size and start to actively
enter the cell cycle from 1 day to 2 days after 70% PHx,
this intervening time could be a period in which hepato-
cytes switch from a hypertrophic phase to a proliferative
phase. The inhibition of cell cycle progression during liver
regeneration has been shown to result in enlarged hepato-
cytes. Large hepatocytes in regenerated liver are observed
in mice deficient for signal transducer and activator of
transcription 3 (Stat3), S phase kinase-associated protein 2
(Skp2), separase or cyclin-dependent kinase 1 (Cdk1)
[44-47]. Similarly, enlarged hepatocytes are observed in
regenerating liver when the cell cycle in hepatocytes is
blocked by dexamethasone [48]. However, our findings in-
dicate that hypertrophy occurs in normal hepatocytes and
precedes cell proliferation in liver regeneration. Import-
antly, the extent of hypertrophy is roughly the same in
liver after 30 and 70% PHx, and hepatocytes do not divide
after 30% PHx. Thus, hypertrophy is the first response in
regeneration, and proliferation follows if hypertrophy is
not sufficient to recover the original mass. In fact, Higginste division. (A) Schematic representation of the labeling assay. Using
enetically labeled by low-frequency expression of LacZ. A singlet that
d hepatocytes (doublet), whereas an undivided singlet would remain
mbers of singlets and doublets. (B) A liver section showing a singlet
fter 70% PHx is shown. The pair of labeled hepatocytes is a doublet
e bar; 25 μm.
Figure 3 Hypertrophy of hepatocytes after PHx. Liver sections stained for actin (green) and nuclei (blue) are shown. The hepatocytes after 70
and 30% PHx are larger than those before PHx. Scale bars: 25 μm.
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trophy of hepatocytes was the first response to the
removal of liver tissue [12].
It is well known that hepatocytes accumulate massive
amounts of lipids and glycogen immediately after 70%
PHx [49-51]. Therefore, the rapid increase in hepatocyte
size is at least partly due to lipid and glycogen accumula-
tion. However, the lipid and glycogen amount decreases
to normal levels by the completion of liver regeneration,
and no obvious change in hepatocyte ultrastructure is
observed in regenerated liver after 70% PHx, with the
exception of enlarged nuclei [38]. Although several re-
ports have shown that hepatocytes change the size and/
or number of various organelles such as mitochondria,
lysosomes, endoplasmic reticulum, and ribosomes
[16-19,52], more studies are necessary to reveal the na-
ture of cellular changes in regeneration. Although the
detailed mechanism of hypertrophy requires further
study, the Akt-mammalian target of rapamycin (mTOR)
signaling axis, which regulates the size of various cell
types [53], seems to be an important pathway for hyper-
trophy in liver regeneration. Akt is a serine-threonine
protein kinase with pleiotropic functions such as regula-
tion of cell growth, proliferation, survival, differentiation,
and cytoskeletal changes. mTOR is another serine-
threonine protein kinase directly phosphorylated by Akt
and plays a central role in the functions of Akt. Akt is
activated immediately after 30 and 70% PHx, and forced
expression of an active form of Akt in hepatocytes
increases their size [[44] and our unpublished data]. An-
other potential key player is c-Myc, which is a transcrip-
tion factor involved in cell growth and cell cycle
progression. Overexpression or deletion of c-Myc in he-
patocytes increases or decreases their size, respectively
[54-56]. Interestingly, both Akt-mTOR and c-Myc path-
ways play critical roles in the enhancement of protein
synthesis, indicating that upregulation of gross protein
synthesis is one mechanism underlying the hypertrophy
of hepatocytes [54,57]. However, the upstream molecular
mechanisms that sense the loss of liver tissue to activateAkt-mTOR and c-Myc pathways remain undefined (see
below).
Because hepatocytes increase their size by 1.5-fold and
then proliferate after 70% PHx, the 1.5-fold increase in
cell size seems to be the threshold for hepatocytes to
switch their response from hypertrophy to proliferation.
As discussed above, this 1.5-fold size increase is suffi-
cient to restore a 30% loss in liver mass, and hepatocytes
do not proliferate after 30% PHx. Therefore, it would be
interesting to determine precisely how much liver mass
must be removed to induce proliferation. The molecular
trigger for hepatocyte proliferation in liver regeneration
is unknown. One possible explanation is that the size of
the hepatocyte itself is the sensor to drive its cell di-
vision cycle, which is considered a general mechanism
for activating cell division [58]. Further studies are
required to address this question.
Hepatocytes infrequently enter M phase
Polyploidy is a characteristic feature in mammalian he-
patocytes, and about 70% of adult hepatocytes in rodents
are tetraploid [59]. In general, polyploid cells can arise
from failed cytokinesis, mitotic slippage, cell fusion or
endoreplication. Polyploid hepatocytes can be either
mononuclear or binuclear. Polyploidization of hepatocytes
is initiated in postnatal liver growth by incomplete cyto-
kinesis, that produces binuclear polyploid hepatocytes,
endoreplication that produces mononuclear polyploid
hepatocytes, or both that produce binuclear polyploid he-
patocytes [37,59,60]. Insulin signaling has been implicated
in the polyploidization and binucleation at the weaning
stage, as discussed below [37,60,61].
While it has long been known that ploidy of hepato-
cytes increases after PHx [14,36,37,62], its mechanism
remains unknown. Although a majority of hepatocytes
undergo S phase in regenerating liver after 70% PHx,
not all hepatocytes undergo cell division, resulting in an
increase in ploidy. We noticed that the ratio of hepato-
cytes that were positive for phosphorylated histone H3
(an M phase marker) to those that were positive for
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much lower than that in postnatal liver, where hepato-
cytes actively undergo cell division [38]. These results
suggest that M phase progression is compromised in
liver regeneration.
M phase promoting factor (MPF), composed of cyclin
B and Cdk1, regulates entry into M phase [63,64], and
MPF must be activated for cell transition from G2 to M
phase. Cdk1 is phosphorylated at three amino acid resi-
dues (Thr-14, Tyr-15, and Thr-161) in the inactive form
of MPF, whereas Cdk1 dephosphorylation at Thr-14 and
Tyr-15 by cell division cycle 25 (Cdc25) activates MPF
[65]. We found that the phosphorylation level of Cdk1
at Tyr-15 was much higher in regenerating liver com-
pared to postnatal liver. Therefore, the lower activity of
MPF in regenerating liver could be a cause of the infre-
quent entry into M phase. In fact, MPF activity is dispens-
able for liver regeneration; hepatocytes increase their size
to regenerate liver after 70% PHx without cell division,
even in the absence of Cdk1 [47].
In contrast to the G2 to M phase transition, the G1 to S
phase transition is driven mainly by cyclin D/A2 and Cdk2
in normal cell division and endoreplication [66]. There-
fore, it is intriguing to compare the activity of Cdk2 in
liver regeneration with that in liver development. As
hepatocytes increase their ploidy in both postnatal liver
development and regeneration, the cell cycle regulators
driving the G1 to S phase transition seem to dominate
those driving the G2 to M phase transition in mature
hepatocytes. Although the exact molecular mechanism
that blocks the entry of hepatocytes into M phase in
regenerating liver remains elusive, a crucial role of the
E2F family transcription factors has been reported recently
[67,68]. The E2F family consists of E2F transcription ac-
tivators and transcription repressors and regulates cell
cycle progression. Using mouse genetic models, these
studies clearly showed that atypical E2F repressors E2F7
and E2F8 inhibit the completion of cell division to
enhance polyploidy and binucleation in hepatocytes
both in liver development and regeneration, whereas
the canonical activator E2F1 counteracts their activities.
These E2Fs differentially control the transcription of
cell cycle regulators to either enhance or inhibit the G2
to M phase transition.
Cell division of binuclear hepatocytes to produce
mononuclear cells
Binucleation is another interesting feature in adult hepa-
tocytes that begins from the neonatal liver [60]. It has
long been known that the number of binuclear hepato-
cytes decreases during liver regeneration after 70% PHx,
as assessed by microscopic observations and manual
counting [13-15,69-71]. Weaning increases the amount
of circulating insulin to activate Akt signaling, whichinduces incomplete cytokinesis to generate binuclear he-
patocytes during liver maturation [37,60,61]. In contrast,
even though Akt is activated by PHx, the number of
binuclear hepatocytes decreases in regenerating liver,
suggesting that Akt has different functions in liver mat-
uration and regeneration. Indeed, Akt signaling induces
hypertrophy of hepatocytes in liver regeneration (our
unpublished data). The different responses to Akt may be
due to the molecular targets of the Akt signaling pathway
differing according to the cellular context. mTOR is a
major downstream molecule of Akt that functions in in-
duction of hypertrophy. Because the E2F family transcrip-
tion factors regulate the progression of M phase [67,68], it
is tempting to speculate a link between Akt signaling and
E2Fs in binucleation. Indeed, it is already known that this
link exits in other cell types [72,73].
To elucidate the cellular basis underlying the reduction
in nuclear number in liver regeneration, we investigated
the behaviors of mononuclear and binuclear hepatocytes
during liver regeneration using the genetic tracing method
and observation of intracellular localization of Aurora B
[38]. The intracellular localization of Aurora B differs
among the M phase steps [74]; therefore, we could distin-
guish hepatocytes in prophase, prometaphase/metaphase,
anaphase and telophase (Figure 4). We found that 32% of
hepatocytes in prophase were binuclear, compared to only
1.9% of cells in prometaphase/metaphase. Furthermore, all
hepatocytes in anaphase showed splitting of the two nuclei
to their two poles, and 93% of pairs of daughter hepato-
cytes in telophase consisted of two mononuclear cells.
Therefore, almost all cell divisions seemed to produce
daughter mononuclear cells irrespective of the nuclear
number of mother hepatocytes. Based on these observa-
tions, we speculate that mononuclear mother cells follow
the normal cell division cycle, whereas binuclear mother
cells gather their chromosomes at the center of the cells
and split two nuclei to two daughter cells again. Consist-
ently, the genetic tracing method showed that almost all
pairs of neighboring daughter hepatocytes produced by
cell division were pairs of two mononuclear hepatocytes
[38]. Interestingly, this mode of cell division of binuclear
hepatocytes was predicted from microscopic observations
of hepatocytes in the early studies of liver regeneration
[13,70]. Moreover, the same mode of cell division was later
reported in vitro [75]. Our results reinforce this older
prediction and suggest that this mode of cell division also
occurs in binuclear hepatocytes in vivo. Although division
of hepatocytes with multipolar spindles has been reported
in vitro [76], further studies are required to address
whether it also occurs in vivo.
Binucleation is generally considered a sign of terminal
differentiation in both hepatocytes and cardiomyocytes
[77,78]; however, in contrast to binuclear hepatocytes,
binuclear cardiomyocytes do not divide. Mononuclear
Figure 4 Hepatocytes in different stages of M phase
distinguished by intracellular localization of Aurora B. A section
of liver stained for Aurora B (red), actin (green), and nuclei (blue) is
shown. The dynamic change in intracellular localization of Aurora B
and nuclear morphology allow discrimination of hepatocytes in
prophase (Pro), prometaphase/metaphase (Meta), anaphase (Ana),
and telophase (Telo). Scale bar: 25 μm.
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functions, and it has been proposed that only mono-
nuclear cardiomyocytes maintain their proliferative poten-
tial to serve as stem or progenitor cells in heart muscle
[79,80]. It is unclear whether hepatocytes with different
numbers of nuclei have different functions. This issue is
discussed further below.
A revised model of liver regeneration
Based on our findings, together with previous observa-
tions, we have proposed a revised model of liver regener-
ation [38]. Upon 30% PHx, the liver recovers its original
mass by increasing the size of hepatocytes, but neither
the cell number nor the nuclear number of hepatocytes
changes. Furthermore, because only a small fraction of
hepatocytes undergo S phase, their ploidy is not altered
significantly (Figure 5A and Table 1). In contrast, when
70% of liver is removed, hypertrophy of hepatocytes
occurs in a few hours after PHx, followed by cell prolifera-
tion. Almost all hepatocytes enter into S phase, but only
about half undergoes cell division to increase their num-
bers. During proliferation, binuclear hepatocytes seem to
preferentially undergo unconventional cell division, in
which chromosomes from two nuclei are split into two
nuclei to produce two mononuclear daughter hepatocytes.
As a result, the nuclear number decreases, whereas ploidyincreases (Figure 5B and Table 1). Although there are still
some other possibilities to be considered, such as hepato-
cyte fusion and/or nuclear fusion during liver regener-
ation, we believe that this revised model represents the
characteristic behavior of hepatocytes during liver regener-
ation and is more accurate than the traditional model.
Cellular robustness of hepatocytes
Adult hepatocytes can be binuclear, polyploid and even
aneuploid under normal conditions [76,81]. Further-
more, cell number, cell size, nuclear number and ploidy
of hepatocytes are significantly different in normal liver
and regenerated liver after 30% or 70% PHx (Table 1).
Despite these differences, liver seems to function almost
equally in different conditions, which raises an intriguing
question whether such differences in the cellular proper-
ties affect hepatocytes. One study using transcriptomic
analysis showed that hepatocytes with different ploidy
were basically indistinguishable [82]; however, another
study indicated that polyploid cells were more resistant
to stressful conditions [83]. Hepatocytes with different
ploidy were shown to be equally susceptible to interferon-γ
(IFN-γ)-induced apoptosis [84]. Proliferation of polyploid
hepatocytes was compromised and they exhibited more
characteristics of senescence [85]. No consensus has been
reached on the functional differences in hepatocytes of
different ploidy or number of nuclei. The volume of hepa-
tocytes is basically proportional to their ploidy, which is
often the case with other cell types [42,84,86,87]. However,
we noticed that hepatocytes increase their size without
increasing their DNA content after 30% PHx [38],
suggesting that hypertrophy without increased ploidy al-
lows hepatocytes to function properly. Naturally occurring
aneuploidy is another feature of hepatocytes, which seems
to arise from inaccurate chromosome segregation [76,81].
Aneuploidy is often associated with genetic disorders and
is observed in various cancers [88,89]. However, aneu-
ploidy does not seem to be tumorigenic in hepatocytes,
and it may even provide genetic diversity in hepatocytes to
perform different functions [81].
In addition to these characteristic features exhibited by
wild-type mice, genetically modified mice show rather
extreme phenotypes of hepatocytes. Mutant mice with
impaired cell cycle progression showed a fully functional
liver with extraordinarily enlarged hepatocytes after 70%
PHx [44-47]. A loss of E2F7 and E2F8 reduced ploidy or
nuclear number but did not affect hepatocyte function
and regeneration after several liver injuries including
PHx [67,68]. Furthermore, hepatocytes were resistant to
DNA damage caused by a lack of telomeric repeat bind-
ing factor 2 (TRF2). In the absence of TRF2, liver
regenerated by increasing the size and ploidy of hepato-
cytes and was fully functional after 70% PHx [90]. These
observations indicate collectively that hepatocytes have a
Figure 5 The revised model of liver regeneration. (A) Liver regeneration after 30% PHx. The median lobe (ML) is removed and the left lobe
(LL), right lobe (RL), and caudate lobe (CL) regrow. During this process, all hepatocytes enlarge, but some enter S phase and divide only rarely. As
a result, hepatocytes slightly increase their ploidy, but do not change their nuclear number. (B) Liver regeneration after 70% PHx. All hepatocytes
increase their size and then enter the cell cycle to undergo S phase. Some cells execute cell division to produce mainly mononuclear daughter
hepatocytes, irrespective of nuclear number of mother hepatocytes. However, not all hepatocytes divide. Liver recovers its lost mass by a
combination of hypertrophy and proliferation. As a result, hepatocytes increase their ploidy, but decrease their nuclear number.
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functions in a variety of settings; these differ in terms of
cell size, ploidy or nuclear number. The observed
extreme plasticity in ploidy of hepatocytes supports
their robustness [76]. It is tempting to speculate that
the cellular robustness of hepatocytes is one reason why
of mammalian organs, only the liver has such a marked
regenerative capacity.
Size control of organs
Liver regeneration serves as an excellent model for regu-
lation of organ size. Generally, differences in organ size
among animals reflect differences in cell number rather
than cell size [91,92]. Limb regeneration in amphibians
also depends on an increase in cell number to fully re-
cover the original tissues. However, the size and numberTable 1 Cellular properties of hepatocytes in regenerated






30% PHx Decreased Increased Unchanged Marginally
increased
70% PHx Decreased Increased Decreased Increasedof hepatocytes in liver regeneration after PHx contribute
differentially to the recovery of liver mass. It has been
suggested that removal of one kidney induces the enlarge-
ment of the other by increasing the size of kidney cells
[93]. Moreover, physiological and pathological cardiac
hyperplasia is induced by hypertrophy of cardiomyocytes
[94,95]. Therefore, cellular hypertrophy could be a general
mechanism for increasing organ size. Hippo/mammalian
Ste-20 like kinase (Mst)1/2-Yorkie/Yes-associated protein
(YAP) signaling plays an indispensable role in the regula-
tion of organ size [96-99]. In normal adult hepatocytes,
Mst1/2 kinase (the mammalian homologue of Drosophila
Hippo) phosphorylates and inactivates YAP (the mamma-
lian homologue of Drosophila Yorkie), which is a tran-
scription activator that induces cell proliferation and
suppresses apoptosis. Transgenic expression of human
YAP in mouse hepatocytes drastically increased the liver
size [96]. This regulation of organ size by Hippo/Mst1/2-
Yorkie/YAP signaling might be due mainly to the control
of proliferation and apoptosis in cells [100]. However,
Hippo/Mst1/2-Yorkie/YAP signaling affects cell size by
tuning Akt-mTOR signaling via miRNA [101], demon-
strating that cell size plays a critical role in organ size
regulation by Hippo/Mst1/2-Yorkie/YAP signaling as well.
Miyaoka and Miyajima Cell Division 2013, 8:8 Page 9 of 12
http://www.celldiv.com/content/8/1/8What senses and regulates liver size is a fundamental
question. The decreased number of hepatocytes and in-
creased size of hepatocytes in regenerated liver suggests
that liver size is determined by the total mass of hepato-
cytes. PHx drastically changes the blood flow into the
liver. This increased blood flow generates shear stress
that induces nitric oxide production, triggering regener-
ation [102-106]. In addition, the amount of bile acid in
the blood might serve as a mechanism of monitoring
the size of liver because it reflects the total mass of the
hepatocytes [107,108]. Additionally, because the liver
serves as a major reservoir of glycogen, the blood
glucose level reflects the liver mass and so might also be
a sensor. Consistent with this hypothesis, it has long
been known that rodents become hypoglycemic after
PHx, and supplementation of glucose inhibits liver re-
generation [109-111]. This inhibitory effect of glucose is
suggested to be mediated by p21 [112]. Other factors in
the regulation of liver size might be cytokines and
serum proteins secreted from hepatocytes. A key con-
tributing feature of these factors is that they must re-
flect the total mass of hepatocytes, but not the number
or size of individual hepatocytes. Although these factors
may sense the liver size, the mechanism of initiating
and promoting regenerative responses remains un-
known. Furthermore, liver regeneration must terminate
when the liver recovers its original mass. Several
molecules have been suggested to be involved in the ter-
mination of liver regeneration including transforming
growth factor-β (TGF-β), a mitoinhibitory cytokine for he-
patocytes [113]; extracellular matrix, which might inhibit
proliferation of hepatocytes via integrin-linked kinase
(ILK) and glypican 3 [114-116]; and peroxisome prol
iferator-activated receptor-γ (PPAR-γ) a mitoinhibitory
transcription factor for hepatocytes [117]. However, the
termination of liver regeneration has been inadequately
studied compared to the initiation process. Recent tran-
scriptome analyses of termination may shed light on its
underlying molecular mechanisms [118,119]. A future
challenge is to elucidate the molecular links between the
sensors of liver size, the factors that regulate the hyper-
trophic and proliferative responses of hepatocytes, and the
termination process of liver regeneration that acts to
maintain the appropriate liver size.
Conclusions
Although liver regeneration has been studied extensively,
many important fundamental mechanisms remain un-
defined such as the mechanisms of cellular hypertrophy,
cell division, nuclear division, ploidy changes and organ
size control. Liver regeneration after PHx provides an
excellent experimental system to tackle such basic bio-
logical questions. Understanding the mechanisms under-
lying liver regeneration is clinically important becausehepatectomy is a practical treatment for liver tumors,
and liver transplantation is an important therapeutic op-
tion in patients with severe liver diseases. Understanding
the mechanism of liver regeneration will lead to the
development of promising therapeutic strategies.
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